Evidence map›Paper›PMID 23507034›Full record

ArticleExperimental neurology2013

Sox10-MCS5 enhancer dynamically tracks human oligodendrocyte progenitor fate.

Suyog U Pol, Jennifer K Lang, Melanie A O'Bara, Thomas R Cimato, Andrew S McCallion, Fraser J Sim

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Transcription factor induction of human oligodendrocyte progenitor fate and differentiation.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Trial
  2. Article
  3. Developing a minimally invasive gene therapy for multiple sclerosis.Molecular therapy. Methods & clinical development · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Muscarinic Receptor MThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Suyog U PolDepartment of Pharmacology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, USA.
Jennifer K Lang
Melanie A O'Bara
Thomas R Cimato
Andrew S McCallion
Fraser J Sim
University at Buffalo, State University of New York · USJohns Hopkins Medicine · US

Funding

Development of a Neuronal Regulatory LexiconR01NS062972 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MCCALLION, ANDREW S · 2009 to 2018
$4.1M
NINDS NIH HHS NS062972NINDS NIH HHS R01 NS062972
6 · The paper itself

Abstract

In this study, we sought to establish a novel method to prospectively and dynamically identify live human oligodendrocyte precursor cells (OPCs) and oligodendrocyte lineage cells from brain dissociates and pluripotent stem cell culture. We selected a highly conserved enhancer element of the Sox10 gene, known as MCS5, which directs reporter expression to oligodendrocyte lineage cells in mouse and zebrafish. We demonstrate that lentiviral Sox10-MCS5 induced expression of GFP at high levels in a subpopulation of human CD140a/PDGFαR-sorted OPCs as well as their immature oligodendrocyte progeny. Furthermore, we show that almost all Sox10-MCS5:GFP(high) cells expressed OPC antigen CD140a and human OPCs expressing SOX10, OLIG2, and PDGFRA mRNAs could be prospectively identified using GFP based fluorescence activated cells sorting alone. Additionally, we established a human induced pluripotent cell (iPSC) line transduced with the Sox10-MCS5:GFP reporter using a Rex-Neo cassette. Similar to human primary cells, GFP expression was restricted to embryoid bodies containing both oligodendrocyte progenitor and oligodendrocyte cells and co-localized with NG2 and O4-positive cells respectively. As such, we have developed a novel reporter system that can track oligodendrocyte commitment in human cells, establishing a valuable tool to improve our understanding and efficiency of human oligodendrocyte derivation.

Indexed as

AntigensCell DifferentiationCells, CulturedChondroitin Sulfate Proteoglycan 4Embryonic Stem CellsEnhancer Elements, GeneticFetusFlow CytometryGreen Fluorescent ProteinsHumansInduced Pluripotent Stem CellsNerve Tissue ProteinsO AntigensOligodendrogliaProteoglycansReceptor, Platelet-Derived Growth Factor alphaAntigensChondroitin Sulfate Proteoglycan 4Green Fluorescent ProteinsNerve Tissue ProteinsO AntigensProteoglycansReceptor, Platelet-Derived Growth Factor alphaSOX10 protein, humanSOXE Transcription FactorsEnhancerLentivirusPluripotentSOX10

Identifiers

PMID23507034
PMCPMC4254711
OpenAlexW2049200123

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.